Markert JM - Search Results

1

Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain.

Oliva CR, Nozell SE, Diers A, McClugage SG 3rd, Sarkaria JN, Markert JM, Darley-Usmar VM, Bailey SM, Gillespie GY, Landar A, Griguer CE. Oliva CR, et al. Among authors: markert jm. J Biol Chem. 2010 Dec 17;285(51):39759-67. doi: 10.1074/jbc.M110.147504. Epub 2010 Sep 24. J Biol Chem. 2010. PMID: 20870728 Free PMC article.

2

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.

Andreansky SS, He B, Gillespie GY, Soroceanu L, Markert J, Chou J, Roizman B, Whitley RJ. Andreansky SS, et al. Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11313-8. doi: 10.1073/pnas.93.21.11313. Proc Natl Acad Sci U S A. 1996. PMID: 8876132 Free PMC article. Review.

3

Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.

Andreansky S, Soroceanu L, Flotte ER, Chou J, Markert JM, Gillespie GY, Roizman B, Whitley RJ. Andreansky S, et al. Among authors: markert jm. Cancer Res. 1997 Apr 15;57(8):1502-9. Cancer Res. 1997. PMID: 9108452

4

Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins.

Andreansky S, He B, van Cott J, McGhee J, Markert JM, Gillespie GY, Roizman B, Whitley RJ. Andreansky S, et al. Among authors: markert jm. Gene Ther. 1998 Jan;5(1):121-30. doi: 10.1038/sj.gt.3300550. Gene Ther. 1998. PMID: 9536273

5

Genetically engineered HSV in the treatment of glioma: a review.

Markert JM, Gillespie GY, Weichselbaum RR, Roizman B, Whitley RJ. Markert JM, et al. Rev Med Virol. 2000 Jan-Feb;10(1):17-30. doi: 10.1002/(sici)1099-1654(200001/02)10:1<17::aid-rmv258>3.0.co;2-g. Rev Med Virol. 2000. PMID: 10654002 Review.

6

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.

Parker JN, Gillespie GY, Love CE, Randall S, Whitley RJ, Markert JM. Parker JN, et al. Among authors: markert jm. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2208-13. doi: 10.1073/pnas.040557897. Proc Natl Acad Sci U S A. 2000. PMID: 10681459 Free PMC article.

7

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

Markert JM, Medlock MD, Rabkin SD, Gillespie GY, Todo T, Hunter WD, Palmer CA, Feigenbaum F, Tornatore C, Tufaro F, Martuza RL. Markert JM, et al. Gene Ther. 2000 May;7(10):867-74. doi: 10.1038/sj.gt.3301205. Gene Ther. 2000. PMID: 10845725 Clinical Trial.

8

Differential gene expression profiling in human brain tumors.

Markert JM, Fuller CM, Gillespie GY, Bubien JK, McLean LA, Hong RL, Lee K, Gullans SR, Mapstone TB, Benos DJ. Markert JM, et al. Physiol Genomics. 2001 Feb 7;5(1):21-33. doi: 10.1152/physiolgenomics.2001.5.1.21. Physiol Genomics. 2001. PMID: 11161003

9

pH alterations "reset" Ca2+ sensitivity of brain Na+ channel 2, a degenerin/epithelial Na+ ion channel, in planar lipid bilayers.

Berdiev BK, Mapstone TB, Markert JM, Gillespie GY, Lockhart J, Fuller CM, Benos DJ. Berdiev BK, et al. Among authors: markert jm. J Biol Chem. 2001 Oct 19;276(42):38755-61. doi: 10.1074/jbc.M107266200. Epub 2001 Aug 20. J Biol Chem. 2001. PMID: 11514582 Free article.

10

Genetically engineered human herpes simplex virus in the treatment of brain tumours.

Markert JM, Parker JN, Gillespie GY, Whitley RJ. Markert JM, et al. Herpes. 2001 Mar;8(1):17-22. Herpes. 2001. PMID: 11867012 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page